Compare $FEMY vs $GTHP | Chartloom

Compare

$FEMY vs $GTHP

Femasys Inc · Guided Therapeutics Inc

FEMY

Femasys Inc

GTHP

Guided Therapeutics Inc

Compare $FEMY vs $GTHP

Comparing Femasys Inc and Guided Therapeutics Inc

FEMYFemasys Inc

GTHPGuided Therapeutics Inc

FEMYFemasys Inc

Market cap

$6M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

1.08x

Rev growth (TTM)

21.9%

YTD performance

-84.3%

52W performance

-83.3%

FCF yield

-301.2%

GTHPGuided Therapeutics Inc

Market cap

$19M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

450.8%

YTD performance

-63.0%

52W performance

-20.0%

FCF yield

-7.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

FEMY

GTHP

Detailed metrics comparison

FEMY

Femasys Inc

GTHP

Guided Therapeutics Inc

Market Cap

FEMY$6M

GTHP$19M

Enterprise Value

FEMY$8M

GTHP$21M

Price

FEMY$2.00

GTHP$0.20

P/E Ratio

FEMYN/A

GTHPN/A

P/S Ratio

FEMY2.63x

GTHP29.70x

EV/Sales

FEMY3.53x

GTHP32.92x

EV/EBITDA

FEMY0.00x

GTHP0.00x

P/B Ratio

FEMY4.26x

GTHP33.42x

P/FCF Ratio

FEMYN/A

GTHPN/A

EV/FCF

FEMY-0.45x

GTHP-14.21x

PEG Ratio

FEMYN/A

GTHPN/A

Forward P/E (NTM)

FEMYN/A

GTHPN/A

Forward P/S (NTM)

FEMY1.08x

GTHPN/A

Revenue (TTM)

FEMY$2M

GTHP$650K

Revenue Growth (YoY)

FEMY21.9%

GTHP450.8%

Forward Rev Growth

FEMY297.9%

GTHP0.0%

Gross Margin (TTM)

FEMY61.0%

GTHP75.8%

Operating Margin (TTM)

FEMY0.0%

GTHP0.0%

EBITDA Margin (TTM)

FEMY-749.3%

GTHP-336.2%

Net Margin (TTM)

FEMY-511.8%

GTHP-560.6%

FCF Margin (TTM)

FEMY-791.0%

GTHP-231.7%

Net Income (TTM)

FEMY$-12M

GTHP$-4M

FCF (TTM)

FEMY$-18M

GTHP$-2M

EPS (TTM)

FEMY-$3.51

GTHP-$0.04

ROE (TTM)

FEMY-21646.0%

GTHP-47148.0%

ROA (TTM)

FEMY-7154.0%

GTHP-24393.0%

ROIC (TTM)

FEMY-12206.0%

GTHP-37126.0%

Cash

FEMY$1M

GTHP$12K

Debt

FEMY$4M

GTHP$2M

Net Cash/Debt

FEMY$-2M

GTHP$-2M

Current Ratio (TTM)

FEMY2.14x

GTHP0.09x

Quick Ratio (TTM)

FEMY0.55x

GTHP0.00x

Debt/Equity (TTM)

FEMY0.87x

GTHP0.60x

Debt/Assets (TTM)

FEMY0.0%

GTHP0.0%

Interest Coverage (TTM)

FEMYN/A

GTHPN/A

Net Debt/EBITDA (TTM)

FEMY0.00x

GTHP0.00x

Beta

FEMY-2.32

GTHP0.69

52W Performance

FEMY-83.3%

GTHP-20.0%

YTD Performance

FEMY-84.3%

GTHP-63.0%

% from 52W High

FEMY-91.0%

GTHP-63.0%

% from 52W Low

FEMY4.2%

GTHP66.7%

Asset Turnover (TTM)

FEMY0.14x

GTHP0.73x

FCF Yield (TTM)

FEMY-301.2%

GTHP-7.8%

Earnings Yield (TTM)

FEMY-194.8%

GTHP-18.9%

Dividend Yield (TTM)

FEMYN/A

GTHPN/A

Rule of 40

FEMY-769.2

GTHP219.2

EV/GP/RG

FEMY0.04

GTHPN/A

Ticker research

View FEMY research View GTHP research

Metric	FEMY Femasys Inc	GTHP Guided Therapeutics Inc
Market & Valuation
Market Cap	$6M	$19M
Enterprise Value	$8M	$21M
Price	$2.00	$0.20
P/E Ratio	N/A	N/A
P/S Ratio	2.63x	29.70x
EV/Sales	3.53x	32.92x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.26x	33.42x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.45x	-14.21x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1.08x	N/A
Revenue & Growth
Revenue (TTM)	$2M	$650K
Revenue Growth (YoY)	21.9%	450.8%
Forward Rev Growth	297.9%	0.0%
Profitability
Gross Margin (TTM)	61.0%	75.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-749.3%	-336.2%
Net Margin (TTM)	-511.8%	-560.6%
FCF Margin (TTM)	-791.0%	-231.7%
Net Income (TTM)	$-12M	$-4M
FCF (TTM)	$-18M	$-2M
EPS (TTM)	-$3.51	-$0.04
ROE (TTM)	-21646.0%	-47148.0%
ROA (TTM)	-7154.0%	-24393.0%
ROIC (TTM)	-12206.0%	-37126.0%
Financial Health
Cash	$1M	$12K
Debt	$4M	$2M
Net Cash/Debt	$-2M	$-2M
Current Ratio (TTM)	2.14x	0.09x
Quick Ratio (TTM)	0.55x	0.00x
Debt/Equity (TTM)	0.87x	0.60x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-2.32	0.69
52W Performance	-83.3%	-20.0%
YTD Performance	-84.3%	-63.0%
% from 52W High	-91.0%	-63.0%
% from 52W Low	4.2%	66.7%
Efficiency & Yields
Asset Turnover (TTM)	0.14x	0.73x
FCF Yield (TTM)	-301.2%	-7.8%
Earnings Yield (TTM)	-194.8%	-18.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-769.2	219.2
EV/GP/RG	0.04	N/A
Ticker research	View FEMY research	View GTHP research

Valuation

P/S Ratio

FEMY

2.63x

GTHP

29.70x

EV/FCF

GTHP

-14.21x

FEMY

-0.45x

Growth & revenue

Revenue Growth TTM

GTHP

450.8%

FEMY

21.9%

Forward Revenue Growth

FEMY

297.9%

GTHP

0.0%

Profitability & performance

Gross Margin

GTHP

75.8%

FEMY

61.0%

ROE

FEMY

-21646.0%

GTHP

-47148.0%

FCF Yield %

GTHP

-7.8%

FEMY

-301.2%

52-Week Performance

GTHP

-20.0%

FEMY

-83.3%

Detailed metrics comparison

FEMY

Femasys Inc

GTHP

Guided Therapeutics Inc

Market Cap

FEMY$6M

GTHP$19M

Enterprise Value

FEMY$8M

GTHP$21M

Price

FEMY$2.00

GTHP$0.20

P/E Ratio

FEMYN/A

GTHPN/A

P/S Ratio

FEMY2.63x

GTHP29.70x

EV/Sales

FEMY3.53x

GTHP32.92x

EV/EBITDA

FEMY0.00x

GTHP0.00x

P/B Ratio

FEMY4.26x

GTHP33.42x

P/FCF Ratio

FEMYN/A

GTHPN/A

EV/FCF

FEMY-0.45x

GTHP-14.21x

PEG Ratio

FEMYN/A

GTHPN/A

Forward P/E (NTM)

FEMYN/A

GTHPN/A

Forward P/S (NTM)

FEMY1.08x

GTHPN/A

Revenue (TTM)

FEMY$2M

GTHP$650K

Revenue Growth (YoY)

FEMY21.9%

GTHP450.8%

Forward Rev Growth

FEMY297.9%

GTHP0.0%

Gross Margin (TTM)

FEMY61.0%

GTHP75.8%

Operating Margin (TTM)

FEMY0.0%

GTHP0.0%

EBITDA Margin (TTM)

FEMY-749.3%

GTHP-336.2%

Net Margin (TTM)

FEMY-511.8%

GTHP-560.6%

FCF Margin (TTM)

FEMY-791.0%

GTHP-231.7%

Net Income (TTM)

FEMY$-12M

GTHP$-4M

FCF (TTM)

FEMY$-18M

GTHP$-2M

EPS (TTM)

FEMY-$3.51

GTHP-$0.04

ROE (TTM)

FEMY-21646.0%

GTHP-47148.0%

ROA (TTM)

FEMY-7154.0%

GTHP-24393.0%

ROIC (TTM)

FEMY-12206.0%

GTHP-37126.0%

Cash

FEMY$1M

GTHP$12K

Debt

FEMY$4M

GTHP$2M

Net Cash/Debt

FEMY$-2M

GTHP$-2M

Current Ratio (TTM)

FEMY2.14x

GTHP0.09x

Quick Ratio (TTM)

FEMY0.55x

GTHP0.00x

Debt/Equity (TTM)

FEMY0.87x

GTHP0.60x

Debt/Assets (TTM)

FEMY0.0%

GTHP0.0%

Interest Coverage (TTM)

FEMYN/A

GTHPN/A

Net Debt/EBITDA (TTM)

FEMY0.00x

GTHP0.00x

Beta

FEMY-2.32

GTHP0.69

52W Performance

FEMY-83.3%

GTHP-20.0%

YTD Performance

FEMY-84.3%

GTHP-63.0%

% from 52W High

FEMY-91.0%

GTHP-63.0%

% from 52W Low

FEMY4.2%

GTHP66.7%

Asset Turnover (TTM)

FEMY0.14x

GTHP0.73x

FCF Yield (TTM)

FEMY-301.2%

GTHP-7.8%

Earnings Yield (TTM)

FEMY-194.8%

GTHP-18.9%

Dividend Yield (TTM)

FEMYN/A

GTHPN/A

Rule of 40

FEMY-769.2

GTHP219.2

EV/GP/RG

FEMY0.04

GTHPN/A

Ticker research

View FEMY research View GTHP research

Metric	FEMY Femasys Inc	GTHP Guided Therapeutics Inc
Market & Valuation
Market Cap	$6M	$19M
Enterprise Value	$8M	$21M
Price	$2.00	$0.20
P/E Ratio	N/A	N/A
P/S Ratio	2.63x	29.70x
EV/Sales	3.53x	32.92x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.26x	33.42x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.45x	-14.21x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1.08x	N/A
Revenue & Growth
Revenue (TTM)	$2M	$650K
Revenue Growth (YoY)	21.9%	450.8%
Forward Rev Growth	297.9%	0.0%
Profitability
Gross Margin (TTM)	61.0%	75.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-749.3%	-336.2%
Net Margin (TTM)	-511.8%	-560.6%
FCF Margin (TTM)	-791.0%	-231.7%
Net Income (TTM)	$-12M	$-4M
FCF (TTM)	$-18M	$-2M
EPS (TTM)	-$3.51	-$0.04
ROE (TTM)	-21646.0%	-47148.0%
ROA (TTM)	-7154.0%	-24393.0%
ROIC (TTM)	-12206.0%	-37126.0%
Financial Health
Cash	$1M	$12K
Debt	$4M	$2M
Net Cash/Debt	$-2M	$-2M
Current Ratio (TTM)	2.14x	0.09x
Quick Ratio (TTM)	0.55x	0.00x
Debt/Equity (TTM)	0.87x	0.60x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-2.32	0.69
52W Performance	-83.3%	-20.0%
YTD Performance	-84.3%	-63.0%
% from 52W High	-91.0%	-63.0%
% from 52W Low	4.2%	66.7%
Efficiency & Yields
Asset Turnover (TTM)	0.14x	0.73x
FCF Yield (TTM)	-301.2%	-7.8%
Earnings Yield (TTM)	-194.8%	-18.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-769.2	219.2
EV/GP/RG	0.04	N/A
Ticker research	View FEMY research	View GTHP research